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Abstract 23 
Glutamate dehydrogenase (GDH) plays a major role in amino acid catabolism. To increase the 24 
current knowledge of GDH function, we analysed the effect of GDH silencing on liver intermediary 25 
metabolism from gilthead sea bream (Sparus aurata). Sequencing of GDH cDNA from S. aurata 26 
revealed high homology with its vertebrate orthologues and allowed us to design short hairpin 27 
RNAs (shRNAs) to knockdown GDH expression. Following validation of shRNA-dependent 28 
downregulation of S. aurata GDH in vitro, chitosan-tripolyphosphate (TPP) nanoparticles 29 
complexed with a plasmid encoding a selected shRNA (pCpG-sh2GDH) were produced to address 30 
the effect of GDH silencing on S. aurata liver metabolism. Seventy-two hours following 31 
intraperitoneal administration of chitosan-TPP-pCpG-sh2GDH, GDH mRNA levels and 32 
immunodetectable protein decreased in the liver, leading to reduced GDH activity in both oxidative 33 
and reductive reactions to about 53-55 % of control values. GDH silencing decreased glutamate, 34 
glutamine and aspartate aminotransferase activity, while increased 2-oxoglutarate content, 2-35 
oxoglutarate dehydrogenase activity and 6-phosphofructo-1-kinase/fructose-1,6-bisphosphatase 36 
activity ratio. Our findings show for the first time that GDH silencing reduces transdeamination and 37 
gluconeogenesis in the liver, hindering the use of amino acids as gluconeogenic substrates and 38 
enabling protein sparing and metabolisation of dietary carbohydrates, which would reduce 39 
environmental impact and production costs of aquaculture. 40 
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1. Introduction 45 
Glutamate dehydrogenase (GDH) plays a major role in amino acid catabolism and ammonia 46 
detoxification in the liver and kidneys through the catalysis of reversible oxidative deamination of 47 
L-glutamate to form α-ketoglutarate and ammonia using NAD(P)+ as cofactor (Lushchak et al., 48 
2008). GDH is a homohexameric enzyme located in the mitocondrial matrix that shows preferential 49 
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reactivity towards the intramitochondrial NADP(H) pool in both reaction directions in vitro, and a 50 
near-equilibrium reaction with the NAD(H) pool. Flux direction of GDH catalysis remains a matter 51 
of debate. Nevertheless, the high Km value of ammonia and NAD+/NADH ratio may direct catalysis 52 
towards oxidative deamination (Karaca et al., 2011; Treberg et al., 2014). GDH activity is 53 
allosterically regulated by a wide array of metabolites in a complex, still not well-understood 54 
manner. GTP strongly inhibits GDH, while ADP activates the enzyme activity. GTP binding to 55 
GDH is antagonised by phosphate and ADP, but is synergistic with NADH. Leucine and other 56 
monocarboxylic acids also activate GDH, while palmitoyl-CoA, diethylstilbestrol and cystein-57 
specific ADP-ribosylation inhibit GDH activity (Li et al., 2014; Plaitakis et al., 2017). It was 58 
suggested that glucose-dependent intracellular formation of glutamate by GDH might amplify 59 
glucose-stimulated insulin secretion in pancreatic β-cells (Göhring and Mulder, 2012; Karaca et al., 60 
2011). Involvement of GDH in insulin secretion was emphasised by the fact that loss of allosteric 61 
inhibition of GDH disturbs insulin secretion. In this regard, activating mutations of GDH cause the 62 
hyperinsulinemia and hyperammonemia syndrome in humans. Indeed, overexpression of GDH in 63 
mice increases insulin secretion (Carobbio et al., 2004), whereas GDH inhibition in pancreatic β-64 
cells impairs insulin secretion (Carobbio et al., 2009). 65 
In fish, the molecular role of GDH remains largely unexplored. Glutamate is primarily 66 
deaminated by GDH in the fish liver leading to concomitant production of ammonia, while in 67 
mammals most glutamate is transaminated to aspartate (Peres and Oliva-Teles, 2006). The effect of 68 
nutritional status on hepatic GDH depends on both species and diet composition. Fasting increases 69 
GDH activity and/or mRNA levels in Oncorhynchus mykiss, Protopterus dolloi, Dentex dentex and 70 
Danio rerio (Frick et al., 2008; Pérez-Jiménez et al., 2012; Sánchez-Muros et al., 1998; Tian et al., 71 
2015). However, starvation did not affect GDH activity in Salmo gairdneri (Tranulis et al., 1991) 72 
and decreased GDH expression in Dicentrarchus labrax and Sparus aurata (Gaspar et al., 2018; 73 
Pérez-Jiménez et al., 2007). High-protein diets stimulate growth and increase plasma free amino 74 
acids, which in turn enhance GDH deamination and ammonia excretion (Bibiano Melo et al., 2006; 75 
Borges et al., 2013; Caballero-Solares et al., 2015; Coutinho et al., 2016; Viegas et al., 2015). In S. 76 
aurata, dietary supplementation with glutamate increases protein retention by stimulation of hepatic 77 
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glucose metabolism and down-regulation of GDH mRNA levels and reductive GDH activity 78 
(Caballero-Solares et al., 2015), while dietary starch decreases GDH activity (Couto et al., 2008). 79 
To better understand the functional role of GDH in the liver, we explored the metabolic effects 80 
resulting from administration of chitosan-tripolyphosphate (TPP) nanoparticles complexed with a 81 
short hairpin RNA (shRNA)-expression plasmid to knockdown GDH expression in the liver of S. 82 
aurata. 83 
 84 
2. Materials and methods 85 
2.1. Rearing procedures 86 
Gilthead seabream (S. aurata) juveniles obtained from Piscimar (Burriana, Castellón, Spain) 87 
were maintained at 20 ºC in 260-L aquaria as described (Fernández et al., 2007). Fish were fed daily 88 
40 g/kg body weight (BW) of a diet containing 58.0 % protein, 9.9 % lipids, 15.0 % carbohydrates, 89 
15.4 % ash, 1.7 % moisture and 20.1 kJ/g gross energy. Chitosan-TPP nanoparticles were 90 
intraperitoneally injected alone or complexed with 10 µg/g BW of pCpG-sh2GDH or pCpG-91 
siRNA-Scramble (control plasmid that expresses a scramble sequence with no homology with 92 
known sequences; InvivoGen, San Diego, CA, USA). Seventy-two hours post-treatment, fish were 93 
sacrificed by cervical section and the liver was immediately dissected out, frozen in liquid N2 and 94 
kept at -80 °C until use. To prevent stress, fish were anesthetised before handling with tricaine 95 
methanesulfonate (1:12,500). Experimental procedures involving fish complied with the guidelines 96 
of the University of Barcelona’s Animal Welfare Committee and EU Directive 2010/63/EU for 97 
animal experiments. 98 
 99 
2.2. Molecular cloning of GDH coding domain sequence from S. aurata 100 
The full-coding sequence of S. aurata GDH was isolated with the First Choice RLM-RACE 101 
Kit (Thermo Fisher Scientific, Waltham, MA, USA) and primers designed from a partial S. aurata 102 
GDH sequence (GenBank accession no. JX073708). Nested PCR was performed with gene-specific 103 
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primers CG1307 and CG1308 for 5’-RACE, as well as CG1306 and CG1305 for 3’-RACE (Table 104 
1). RACE products were ligated into pGEM-T Easy (Promega, Madison, WI, USA) and sequenced 105 
on both strands. The full-coding sequence of S. aurata GDH was amplified from the liver by RT-106 
PCR using primer pair CG1333/CG1334 (Table 1), ligated into pGEM-T Easy to generate pGEM-107 
GDH, and fully sequenced. 108 
 109 
2.3. Expression plasmids 110 
To generate pcDNA3-GDH, the coding domain sequence of GDH was amplified by PCR 111 
using primer pair CG1526/CG1527 and pGEM-GDH as template. The resulting fragment was 112 
digested with BamHI and EcoRI and ligated into pcDNA3 (Life Technologies, Carlsbad, CA, USA) 113 
previously digested with the same enzymes. To obtain pCpG-sh1GDH, pCpG-sh2GDH, pCpG-114 
sh3GDH, pCpG-sh4GDH and pCpG-sh5GDH, oligonucleotide pairs CG1531/CG1532, 115 
CG1533/CG1534 CG1535/CG1536, CG1537/CG1538 and CG1539/CG1540 (Table 1), 116 
respectively, were mixed at a final concentration of 25 µM each, heated a 90 ºC for 5 min and 117 
cooled down at room temperature. One hundred ng of double-stranded products were ligated into 118 
pCpG-siRNA (InvivoGen, San Diego, CA, USA) previously digested with HindIII and Acc65I. 119 
shRNA sequences were designed using siRNA Wizard software (InvivoGen, San Diego, CA, USA). 120 
 121 
2.4. Preparation and characterisation of chitosan-TPP-DNA nanoparticles 122 
Chitosan-TPP nanoparticles complexed with pCpG-siRNA-Scramble or pCpG-sh2GDH were 123 
prepared following the ionic gelation method as described (González et al., 2016). Three-hundred 124 
µg of pCpG-siRNA-Scramble or pCpG-sh2GDH were added to 1.2 ml of 0.84 mg/ml TPP. 125 
Thereafter, TPP-DNA solutions were added dropwise to 3 ml of 2 mg/ml low molecular weight 126 
chitosan-acetate buffer (1:0.4 chitosan/TPP ratio). Chitosan-TPP-DNA nanoparticles were pelleted, 127 
rinsed twice with ultrapure water and resuspended in 2 ml of 2 % w/v mannitol as cryoprotector 128 
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during lyophilisation. After a freeze–dry cycle at −47 °C, an additional drying step was performed 129 
at 25 °C to remove residual water. Chitosan-TPP-DNA nanoparticles were characterised by atomic 130 
force microscopy using peak force tapping mode (Multimode 8 AFM attached to a Nanoscope III 131 
Electronics, Bruker, USA). Z potential was determined using laser Doppler microelectrophoresis in 132 
a Zetasizer NanoZ equipped with DTS1060 capillary cells (Malvern Instruments, Malvern, UK). 133 
Chitosan-TPP-DNA nanoparticles were resuspended in 0.9 % NaCl previous administration to S. 134 
aurata. 135 
 136 
2.5. Cell culture and transfection  137 
HepG2 cells (ATCC HB 8065) were cultured in DMEM supplemented with 2 mM glutamine, 138 
110 mg/l sodium pyruvate, 10 % foetal bovine serum, 100 IU/ml penicillin and 100 µg/ml 139 
streptomycin. Cells were grown at 37 ºC and 5 % CO2 in 6-well plates. The calcium phosphate 140 
coprecipitation method (Graham and van der Eb, 1973) was used for transient transfection of 141 
HepG2 cells at 45-50 % confluence with 30-300 ng pcDNA3-GDH, 600 ng of pCpG-siRNA-142 
Scramble or GDH-specific shRNA expression constructs, and 300 ng pCMV-β (lacZ) to correct for 143 
variations in transfection efficiency. Empty plasmids were added to each transfection to ensure 144 
equal DNA amounts. Forty-eight hours post-transfection, the cells were harvested, washed in PBS 145 
and lysed to isolate total RNA. β-Galactosidase activity in 20-50 µl of the clear lysate was 146 
measured as described (Metón et al., 2006). 147 
 148 
2.6. Quantitative RT-PCR 149 
One µg of total RNA isolated from HepG2 cells or S. aurata liver was reverse-transcribed to 150 
cDNA using random hexamer primers and Moloney murine leukaemia virus RT (Life technologies, 151 
Carsbad, CA, USA) for 1 h at 37 ºC. S. aurata GDH mRNA levels were determined in a Step One 152 
Plus Real Time PCR System (Applied Biosystems, Foster City, CA, USA) in a 20-µl mixture 153 
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containing 0.4 µM of each primer, 10 µl of SYBR Green (Applied Biosystems, Foster City, CA, 154 
USA), and 1.6 µl of diluted cDNA. The temperature cycle protocol for amplification was 95 °C for 155 
10 min, followed by 40 cycles with 95 °C for 15 s and 62 °C for 1 min. A dissociation curve was 156 
run after each experiment to confirm single product amplification. Amplification specificity was 157 
confirmed by sequencing. S. aurata GDH mRNA was amplified with primer pair CG1543/CG1544 158 
(Table 1). The expression of S. aurata GDH in transfected HepG2 cells was normalised with 159 
ribosomal subunit 18s (primer pair MC109/MC110; Table 1) and β-galactosidase (primer pair 160 
JDRTCMVBS/JDRTCMVBAS; Table 1). For in vivo experiments, mRNA levels were normalised 161 
with S. aurata ribosomal subunit 18s, β-actin and elongation factor 1 α (EF1α) using primer pairs 162 
JDRT18S/JDRT18AS, QBACTINF/QBACTINR and AS-EF1Fw/AS-EF1Rv, respectively (Table 163 
1). Variations in gene expression were calculated by the standard ΔΔCT method (Pfaffl, 2001). 164 
 165 
2.7. Western blotting analysis 166 
Liver extracts were loaded to a 10% SDS-PAGE gel. After electrophoresis, the gel was 167 
equilibrated in transfer buffer (25 mM Tris-HCl, 192 mM glycine, 20 % methanol, pH 8.3) and 168 
electroeluted onto a polyvinylidene fluoride membrane for 3 hours at 60 V and 4 ºC. After 169 
incubation in blocking buffer (non-fat skim milk powder 5 % w/v, 50 mM Tris-base pH 7.5, 100 170 
mM NaCl, 0.1 % Tween 20), the membrane was exposed to rabbit anti-GDH (OriGene, Rockville, 171 
MD, USA) and mouse anti-actin (Sigma-Aldrich, Saint Louis, MO, USA) as primary antibodies 172 
(1:1000). Immunodetection was performed using an alkaline phosphatase-conjugated secondary 173 
antibody (Sigma-Aldrich, Saint Louis, MO, USA; 1:3000) and the Clarity Western ECL Substrate 174 
Kit (Bio-Rad, Hercules, CA, USA). 175 
 176 
2.8. Enzyme activity assays and metabolite determinations 177 
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Liver crude extracts for enzyme activity assays were obtained as described (Caballero-Solares 178 
et al., 2015). GDH was assayed in the direction of L-glutamate formation (reductive reaction) by 179 
monitoring NADH oxidation at 340 nm in a 250-µl mixture containing 50 mM imidazole-HCl pH 180 
7.4, 250 mM ammonium acetate, 5 mM 2-oxoglutarate, 0.1 mM NADH, 1 mM ADP and 4 µl crude 181 
extract. To measure GDH reaction in the direction of 2-oxoglutarate synthesis (oxidative reaction), 182 
NADH formation was followed at 340 nm in a 200-µl assay containing 154 mM tris-HCl pH 9.0, 20 183 
mM L-glutamate, 100 mM hydrazine, 1 mM NAD+, 1 mM ADP and 4 µl crude extract. 2-184 
Oxoglutarate dehydrogenase (OGDH) activity was assayed after addition of 0.12 mM coenzyme A 185 
to a final volume of 200 µl containing 50 mM phosphate buffer pH 7.4, 2 mM MgCl2, 0.6 mM 186 
thiamine pyrophosphate, 2 mM NAD+, 10 mM 2-oxoglutarate, 0.2 mM EGTA, 0.4 mM ADP and 4 187 
µl crude extract. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were 188 
determined with commercial kits (Linear Chemicals, Montgat, Barcelona, Spain). 6-Phosphofructo-189 
1-kinase (PFK), fructose-1,6-bisphosphatase (FBP1) and total protein were assayed as described 190 
(Metón et al., 1999). One unit of enzyme activity was defined as the amount of enzyme necessary to 191 
transform 1 µmol of substrate per min. 2-Oxoglutarate was determined by monitoring NADH 192 
oxidation at 340 nm in a 200-µl assay containing 50 mM imidazole-HCl pH 7.4, 0.1 mM NADH, 193 
0.37 U/mL GDH and 75 µl liver trichloroacetic acid extract. Spectrophotometric determinations 194 
were performed at 30 °C in a Cobas Mira S analyser (Hoffman-La Roche, Basel, Switzerland).  195 
 196 
2.9. Amino acid analysis 197 
Amino acids and related molecules were analysed on filtered liver trifluoroacetic acid extracts 198 
by cation-exchange chromatography followed by post-column derivatisation with ninhydrin and 199 
UV/VIS detection (Moore et al., 1958). Chromatographic separation was performed using a 200 
Biochrom 30 amino acid analyser equipped with PEEK column packed with Ultropac cation-201 
 9 
exchange resin (Lithium High Performance Physiological Column) and Peltier heating/cooling 202 
system (Biochrom, Cambridge, UK). Following sample injection, a gradient elution was applied by 203 
combining five lithium citrate buffers of increasing pH (2.80 to 3.55) and ionic strength (0.2 M to 204 
1.65 M). Column effluents reacted with ninhydrin at 135 ºC and derivatised amino acids were 205 
detected at 570 nm and 440 nm wavelenghts. Amino acid peaks were identified according to the 206 
retention times of amino acid standards. Addition of L-norleucine to each sample allowed 207 
calculation of amino acid concentration by the internal standard method. Data analysis was 208 
performed with EZChrom Elite software (Agilent Technologies, Santa Clara, CA, USA). 209 
 210 
2.10. Statistics 211 
Analyses were performed with SPSS software Version 22 (IBM, Armonk, NY, USA). 212 
Statistical analysis with two levels was determined using Student’s t test. One-way ANOVA 213 
statistical differences among three or more levels were determined with the Bonferroni post hoc 214 
test. 215 
 216 
3. Results 217 
3.1. Molecular cloning of the full-coding sequence of S. aurata GDH 218 
A 2,715 bp cDNA encoding GDH was isolated by RACE PCR performed on total RNA from 219 
S. aurata liver. The S. aurata GDH nucleotide sequence was deposited to the GenBank database 220 
under accession no. MF459045. The GDH cDNA contains a 1,629-bp open reading frame and a 221 
consensus polyadenylation signal (AATAAA) 20 bp upstream from the poly(A+) tail. The deduced 222 
amino acid sequence of S. aurata GDH predicts a polypeptide of 542 residues with a calculated 223 
molecular mass of 59.67 kDa. Computer analysis with TargetP 1.1 (Emanuelsson et al., 2000; 224 
Nielsen et al., 1997) indicated that GDH cDNA contains a mitochondrial targeting peptide with 225 
putative cleavage site at position 20. The inferred amino acid sequence of S. aurata GDH was 226 
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aligned with GDH orthologues in other vertebrates to explore evolutionary relationships (Fig. 1A). 227 
S. aurata GDH retains all residues considered important for glutamate and GTP binding (15 and 16 228 
residues, respectively) and most residues involved in the binding to NAD+ (20 out of 25), ADP (26 229 
out of 27) and thiamine pyrophosphate (5 out of 6) (Bunik et al., 2016). Pair-wise alignments 230 
allowed us to generate a phylogenetic tree (Fig. 1B). Amongst fish, S. aurata GDH exhibited higher 231 
similarity with sequences reported for Lates calcarifer, Nothobranchius furzeri, Paralichthys 232 
olivaceus and Xiphophorus maculatus (96.3-97.1 % of identity). A lower identity was observed 233 
when compared to Salmo salar (92.6 %) and Danio rerio (87.5 %). Concerning mammalian 234 
orthologues, S. aurata GDH shared 81.2 to 84.3 % identity with Mus musculus, Rattus norvegicus 235 
and Homo sapiens GDH.  236 
 237 
3.2. Validation of shRNA expression constructs to silence S. aurata GDH in HepG2 cells 238 
Five shRNA (named sh1 to sh5) designed to knockdown S. aurata GDH were subcloned into 239 
pCpG-siRNA, a vector that allows long lasting expression of small interfering RNA (siRNA) in 240 
vivo. Efficiency of GDH silencing for the resulting constructs (pCpG-sh1GDH to pCpG-sh5GDH) 241 
was validated in HepG2 cells co-transfected with 30 ng or 300 ng of a construct expressing S. 242 
aurata GDH (pcDNA3-GDH), 300 ng of pCMV-β and 600 ng of pCpG-sh1GDH, pCpG-sh2GDH, 243 
pCpG-sh3GDH, pCpG-sh4GDH, pCpG-sh5GDH or pCpG-siRNA-Scramble (control). Forty-eight 244 
hours later, the cells were lysed and RNA isolated to perform RT-qPCR assays to determine S. 245 
aurata GDH mRNA levels. Three shRNAs (sh2, sh3 and sh5) significantly decreased GDH 246 
expression in HepG2 cells co-transfected with 30 ng of pcDNA3-GDH, while sh2 was the only that 247 
significantly down-regulated GDH mRNA in the cells co-transfected with a higher concentration of 248 
pcDNA3-GDH (300 ng). In all cases, the highest GDH gene silencing effect was observed with sh2, 249 
which reduced values to 21 % and 55 % of controls (Scramble) after co-tranfection with 30 ng and 250 
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300 ng of pcDNA3-GDH, respectively (Fig. 2A). Therefore, sh2 was selected for subsequent 251 
studies. 252 
 253 
3.3. Effect of chitosan-TPP-pCpG-sh2GDH administration on GDH expression in the liver of S. 254 
aurata 255 
To study the metabolic effects of GDH silencing, chitosan-TPP nanoparticles were complexed 256 
with pCpG-sh2GDH to deliver and express sh2 into S. aurata liver cells. Schematic representation 257 
of chitosan-TPP-DNA nanoparticles is shown in Figure 2B. Atomic force microscopy on chitosan-258 
TPP nanoparticles showed a rounded morphology with mean diameter size ± SD (n=6) of 224.0 nm 259 
± 62.4 (Fig. 2C), and presented a mean Z potential of 32.98 mV ± 1.16. Incorporation of pCpG-260 
siRNA constructs to chitosan-TPP nanoparticles did not significantly affect morphology or mean 261 
diameter size, while reduced mean Z potential to 14.37 mV ± 1.29. Three groups of fish received an 262 
intraperitoneal injection of chitosan-TPP-pCpG-sh2GDH (10 µg of plasmid/g BW), chitosan-TPP-263 
pCpG-siRNA-Scramble (10 µg of plasmid/g BW; negative control) or chitosan-TPP nanoparticles 264 
(negative control of chitosan-TPP not complexed with DNA). GDH mRNA levels, 265 
immunodetectable protein and enzyme activity were determined in the liver at 72 hours post-266 
treatment. As expected, inclusion of pCpG-siRNA-Scramble into chitosan-TPP nanoparticles did 267 
not affect GDH mRNA levels in the liver. However, administration of chitosan-TPP-pCpG-268 
sh2GDH significantly decreased GDH expression to 41 % of control values (Scramble) (Fig. 2B). 269 
Consistent with sh2-mediated down-regulation of GDH mRNA, treatment with pCpG-sh2GDH 270 
decreased immunodetectable GDH protein in liver extracts and decreased GDH activity in both 271 
oxidative and reductive reactions to about 53-55 % of control values (Fig. 3A).  272 
 273 
3.4 Effect of GDH knockdown on the hepatic intermediary metabolism of S. aurata 274 
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The effect of GDH silencing was also studied on hepatic key enzyme activities involved in 275 
amino acid metabolism, glycolysis-gluconeogenesis and the Krebs cycle, 2-oxoglutarate levels and 276 
amino acid profile. In regard of amino acid metabolism, knockdown of GDH significantly 277 
decreased AST activity to about 73 % of control levels. Albeit not significant, the same trend was 278 
observed for ALT (Fig. 3B). We also addressed the effect of GDH silencing on PFK and FBP1 279 
activity, which exert a major role in glucose homeostasis by controlling the flux through the 280 
fructose-6-phosphate/fructose-1,6-bisphosphate substrate cycle. GDH knockdown did not affect 281 
PFK activity, but significantly reduced FBP1 activity to 63 % of controls. Therefore, the PFK/FBP1 282 
ratio increased to 122 % as a result of GDH silencing (Fig. 3C). The hepatic content of 2-283 
oxoglutarate, a substrate of the reductive GDH reaction, significantly increased to 172 % in the liver 284 
of fish treated with chitosan-TPP-pCpG-sh2GDH. Given that 2-oxoglutarate is also a substrate of 285 
OGDH, a rate-limiting complex of the Krebs cycle, we analysed OGDH activity in the liver. GDH 286 
silencing increased OGDH activity to 135 % (Fig. 3D). Since GDH has a major role in liver amino 287 
acid catabolism through oxidative deamination of L-glutamate, changes in amino acid and related 288 
molecules profile resulting from GDH silencing were also determined. Administration of chitosan-289 
TPP-pCpG-sh2GDH nanoparticles significantly decreased glutamate and glutamine to 80 % and 64 290 
% of their respective controls. GDH silencing also decreased α-aminobutyric acid to 76 % of 291 
control values, while increased 1.2-fold methionine levels (Table 2). 292 
 293 
4. Discussion 294 
Teleost fish use efficiently amino acids for growth and to obtain energy, while exhibit slower 295 
dietary carbohydrate digestion and free sugar metabolisation than mammals, giving rise to 296 
prolonged hyperglycemia. Therefore, optimal growth of fish requires high levels of dietary protein 297 
(Moon, 2001; Polakof et al., 2012). However, a reduction in the amount of protein in aquafeeds 298 
would alleviate dependence on wild fisheries and the environmental impact of aquaculture (Gormaz 299 
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et al., 2014; Martinez-Porchas and Martinez-Cordova, 2012; Naylor et al., 2000). The main site of 300 
amino acid catabolism is the liver and primarily involves transdeamination, in which the amino 301 
group of a variety of amino acids is transferred to 2-oxoglutarate to produce glutamate, which in 302 
turn can be deaminated by GDH. The fact that the molecular role of GDH in fish remains largely 303 
unexplored prompted us to study the effect of GDH silencing on S. aurata liver intermediary 304 
metabolism. To this end, the full length GDH cDNA sequence from S. aurata was isolated. As 305 
expected, alignment of the inferred peptide sequence of S. aurata GDH with those reported for 306 
other fish species gave the highest identity (>96 %) with species from the Percomorphaceae 307 
subdivision (Lates calcarifer, Nothobranchius furzeri, Paralichthys olivaceus and Xiphophorus 308 
maculatus), the subdivision to which S. aurata belongs. A slightly lower identity was found when 309 
compared to phylogenetically distant fish species, such as Salmoniformes (Salmo salar) and 310 
Cypriniformes (Danio rerio).  311 
S. aurata GDH retains all residues involved in glutamate binding and GTP inhibition (31 in 312 
total), and most of the residues considered of importance for NAD+ and thiamine pyrophosphate 313 
binding, and ADP activation (51 out of 58) (Bunik et al., 2016). Indeed, analysis of non-conserved 314 
amino acids involved in catalysis and allosteric regulation of GDH reveals that 6 out of 7 are 315 
conservative mutations. The only significant difference between species from the Percomorphaceae 316 
subdivision (including S. aurata) and mammalian GDH resides in the substitution of a serine 317 
residue involved in NAD+ binding by Gly368 in S. aurata GDH. Taken together, the overall 318 
similarity with mammalian GDH suggests a high degree of conservation of the structure and 319 
conceivably the reaction mechanism during vertebrate evolution. 320 
Availability of S. aurata GDH cDNA sequence allowed us to design shRNAs to knockdown 321 
GDH expression and analyse the metabolic effects derived from GDH silencing. Validation of five 322 
selected shRNAs was performed in HepG2 cells co-transfected with shRNA and S. aurata GDH 323 
expression plasmids. The most effective shRNA in vitro (sh2) was subsequently chosen to evaluate 324 
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metabolic effects of GDH gene silencing in vivo. As a vector to deliver pCpG-sh2GDH (sh2 325 
expression plasmid) into S. aurata hepatocytes, we used chitosan, which is a cationic polymer 326 
composed of glucosamine and N-acetylglucamosine, derived from chitin by deacetylation. 327 
Mucoadhesion, low toxicity, biodegradability and biocompatibility of chitosan led in recent years to 328 
increasing use of chitosan as a carrier to facilitate incorporation of DNA constructs into host cells in 329 
vivo (Ragelle et al., 2014; Sáez et al., 2017). Recently, administration of chitosan-TPP-DNA 330 
nanoparticles to knockdown S. aurata cytosolic ALT allowed us to demonstrate that cytosolic ALT 331 
silencing enhanced rate-limiting activities of glycolysis, while did not affect gluconeogenesis 332 
(González et al., 2016). Based on this methodology, in the present study we used the ionic gelation 333 
technique, a method based on interactions between low molecular weight chitosan and polyanions 334 
such as TPP (Fàbregas et al., 2013), to encapsulate pCpG-sh2GDH and analyse the effect of GDH 335 
silencing on the hepatic metabolism of S. aurata. Seventy-two hours following intraperitoneal 336 
administration of chitosan-TPP-pCpG-sh2GDH, the hepatic expression of GDH was significantly 337 
reduced at mRNA level, immunodetectable protein and reductive and oxidative enzyme activity. No 338 
sickness, death or behavioural alterations were observed as a consequence of GDH silencing. 339 
Similarly as in S. aurata, previous studies showed that although GDH deletion leads to deficient 340 
oxidative metabolism of glutamate in the central nervous system, brain-specific Glud1 null mice 341 
were viable, fertile and without apparent behavioural problems (Frigerio et al., 2012). 342 
Consistent with the liver as the main site for GDH expression, GDH silencing promoted 343 
significant changes on the hepatic levels of GDH substrates and products: glutamate and 2-344 
oxoglutarate. As a result of GDH silencing, 2-oxoglutarate levels increased in the liver of S. aurata. 345 
Elevated 2-oxoglutarate values may determine enhancement of OGDH activity, a key enzyme 346 
complex of the Krebs cycle. In agreement with increased 2-oxoglutarate levels, a decreased GDH 347 
activity led to the opposite effects on the hepatic content of glutamate. Since 2-oxoglutarate can be 348 
converted to glutamate by either GDH or transaminases, it is conceivable that low glutamate levels 349 
were reinforced by inhibition of ALT and AST, which are considered the more relevant 350 
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aminotransferases in the liver. Altogether, our findings point to decreased transaminase activity and 351 
reduced transdeamination resulting from GDH silencing in the S. aurata liver. Indeed, given that 352 
glutamine synthetase can synthesise glutamine from glutamate, the low levels of glutamate may be 353 
responsible for decreased glutamine values in the liver of fish treated with chitosan-TPP-pCpG-354 
sh2GDH.  355 
Bearing in mind that methionine is an essential amino acid in animals, the fact that 356 
methionine levels were higher in the liver of fish treated with chitosan-TPP-pCpG-sh2GDH 357 
nanoparticles suggests that GDH silencing decreased methionine metabolism, which in turn may 358 
result in reduced α-aminobutyric acid levels. Considering that it was recently reported that high 359 
protein diets increase α-aminobutyric acid in humans (Haschke-Becher et al., 2016), the low levels 360 
of α-aminobutyric acid in the liver of treated fish can also be a consequence of decreased amino 361 
acid metabolism as a result of GDH silencing. 362 
In a context with reduced transdeaminating capacity, the use of amino acids as glucogenic and 363 
ketogenic substrates, and to produce energy by entering catabolic pathways, could be compromised. 364 
In this regard, it is remarkable that GDH knockdown increased PFK/FBP1 activity ratio, which 365 
suggests that glycolysis was favoured over gluconeogenesis in the liver of treated fish. This 366 
metabolic shift could enhance the use of dietary carbohydrates as fuel for energy production as a 367 
compensatory mechanism resulting from impaired transdeamination and reduced entrance of the 368 
carbon skeleton of amino acids into the Krebs cycle to obtain energy and as gluconeogenic 369 
substrates. Our findings are consistent with increased glucose utilisation in cultured mice astrocytes 370 
treated with siRNA to knockdown GDH expression (Pajęcka et al., 2015). The authors concluded 371 
that glucose could replace glutamate as energy substrate in GDH-deficient cells on the basis that 372 
siRNA-treated astrocytes were able to maintain physiological levels of ATP regardless of GDH 373 
expression by increasing glucose oxidation. Furthermore, consistent with the rise in OGDH 374 
complex activity and elevated 2-oxoglutarate levels in the liver of S. aurata treated with chitosan-375 
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TPP-pCpG-sh2GDH nanoparticles, GDH deficient astrocytes exhibit an increased glucose 376 
metabolism linked to elevated Krebs cycle flux from 2-oxoglutarate to oxaloacetate and up-377 
regulation of anaplerotic pathways such as pyruvate carboxylase to maintain the amount of Krebs 378 
cycle intermediates (Nissen et al., 2015). Indeed, transgenic mice expressing human GDH2 showed 379 
a general decrease in oxidative glucose metabolism (Nissen et al., 2017).  380 
By hindering the use of amino acids as gluconeogenic substrates and favouring glucose 381 
oxidation in the liver of S. aurata, GDH silencing may enable partial substitution of dietary protein 382 
by carbohydrates in aquafeeds. Fishmeal is the main protein source in fish farming and it is 383 
obtained by processing an important part of wild fish captures. Therefore, a reduction in the amount 384 
of protein in aquafeeds would alleviate dependence on wild fisheries and decrease local 385 
eutrophication resulting from amino acid oxidation and ammonia release of excess dietary protein. 386 
In addition to reduce environmental impact of aquaculture, substitution of dietary protein by 387 
cheaper nutrients such as carbohydrates, would decrease production costs. 388 
In conclusion, we addressed the metabolic effects of GDH silencing in the liver of S. aurata. 389 
Data presented suggest that knockdown of GDH expression reduces hepatic transdeamination and 390 
compromises the use of amino acids as gluconeogenic substrates. Our findings point to GDH 391 
silencing as a target to spare protein, stimulate glucose metabolism and reduce environmental 392 
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Figure captions 549 
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Fig. 1. Multiple alignment and phylogenetic tree of GDH. (A) Alignment of the predicted amino 550 
acid sequence of S. aurata GDH with GDH orthologues in other vertebrates. Black, identical amino 551 
acids; grey, conservative amino acid substitutions. Letters on the top indicate residues involved in 552 
the binding to ADP (A), glutamate (E), GTP (G), NAD+ (N) and thiamine pyrophosphate (T). 553 
GenBank entries shown are: Sparus aurata (MF459045); Nothobranchius furzeri (XP_015818399); 554 
Xiphophorus maculatus (XP_005794695); Lates calcarifer (XP_018531054), Paralichthys 555 
olivaceus (XP_019938702), Salmo salar (NP_001117108), Danio rerio (NP_997741), Mus 556 
musculus GDH1 (NP_032159), Rattus norvegicus GDH1 (NP_036702), Homo sapiens GDH1 557 
(NP_005262) and Homo sapiens GDH2 (NP_036216). (B) Phylogenetic tree for GDH. Multiple 558 
alignment and phylogenetic tree were made with Clustal Omega (Sievers et al., 2011), PhyML 559 
(Guindon et al., 2010), and TreeDyn (Chevenet et al., 2006). 560 
 561 
Fig. 2. In vitro validation of shRNA-mediated silencing of S. aurata GDH and effect of chitosan-562 
TPP-DNA nanoparticles on hepatic GDH mRNA levels in S. aurata. (A) HepG2 cells were co-563 
transfected with of pcDNA3-GDH (30 ng or 300 ng), pCMV-β (300 ng) and pCpG-sh1GDH, 564 
pCpG-sh2GDH, pCpG-sh3GDH, pCpG-sh4GDH or pCpG-sh5GDH (600 ng). S. aurata GDH 565 
mRNA levels at 48 hours post-transfection were analysed by RT-qPCR and normalised with human 566 
ribosomal subunit 18s and β-galactosidase (internal control of transfection). (B) Molecular structure 567 
and electrostatic interactions of chitosan-TPP-DNA nanoparticles. (C) The left part of the panel 568 
shows representative images of chitosan-TPP, chitosan-TPP-pCpG-siRNA-Scramble and chitosan-569 
TPP-pCpG-sh2GDH nanoparticles obtained by atomic force microscopy. White bars correspond to 570 
200 nm. The right part of the panel shows the effect of nanoparticle administration on GDH mRNA 571 
levels in the S. aurata liver. Three groups of fish were intraperitoneally injected with chitosan-TPP 572 
(Chitosan), chitosan-TPP-pCpG-siRNA-Scramble (Scramble; 10 µg of plasmid/g BW) or chitosan-573 
TPP-pCpG-sh2GDH (sh2; 10 µg of plasmid/g BW). Analysis of GDH mRNA levels relative to the 574 
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geometric mean of ribosomal subunit 18s, β-actin and EF1α were performed by RT-qPCR in liver 575 
samples of S. aurata at 72 hours post-treatment. The values are expressed as mean ± SD (n=4, in 576 
vitro analysis; n=6, in vivo analysis). Statistical significance related to control (Scramble) is 577 
indicated as follows: **P < 0.01; ***P < 0.001. 578 
 579 
Fig. 3. Effect of chitosan-TPP-DNA nanoparticles on GDH protein and activity, 2-oxoglutarate 580 
content and key enzyme activities in the S. aurata liver metabolism. (A) Effect of GDH silencing on 581 
immunodetectable GDH protein, shown as a representative Western blot (upper part of the panel), 582 
and reductive and oxidative GDH activity (lower part of the panel). (B) Effect of GDH silencing on 583 
ALT and AST activity. (C) Effect of GDH silencing on PFK and FBP1 activity, and PFK/FBP1 584 
activity ratio. (D) Effect of GDH silencing on 2-oxoglutarate levels and OGDH activity. GDH 585 
immunodetectable protein, enzyme activities and 2-oxoglutarate content were assayed in liver crude 586 
extracts 72 hours after administration of 10 µg/g BW of pCpG-siRNA-Scramble (Scramble) or 587 
chitosan-TPP-pCpG-sh2GDH (sh2). 2-Oxoglutarate concentration and enzyme specific activities 588 
are expressed as mean ± SD (n=6). Statistical significance related to control (Scramble) is indicated 589 
as follows: *P < 0.05; **P < 0.01.  590 
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Table 1. Oligonucleotides used in the present study. 591 









































The following primers contain restriction sites (underlined): CG1526 (BamHI) and CG1527 593 
(EcoRI).  594 
 27 





Taurine 11.96±0.57 12.18±0.80 
Urea 2.78±0.45 2.77±0.35 
Aspartate 1.90±0.15 2.09±0.17 
Threonine 2.54±0.10 3.08±0.68 
Serine 0.37±0.04 0.36±0.13 
Asparagine 0.28±0.13 0.29±0.11 
Glutamate 5.37±0.53 4.30*±0.40 
Glutamine 1.46±0.16 0.94**±0.05 
Sarcosine 6.89±1.42 6.48±0.86 
Proline 0.52±0.21 0.71±0.08 
Glycine 2.33±0.39 2.57±0.54 
Alanine 7.94±1.18 7.95±0.70 
α-Aminobutyric acid 0.16±0.02 0.12*±0.03 
Valine 0.14±0.02 0.18±0.03 
Methionine 0.13±0.02 0.16*±0.02 
Cystathionine 0.51±0.09 0.59±0.33 
Isoleucine 0.13±0.01 0.11±0.01 
Leucine 0.20±0.02 0.21±0.03 
Tyrosine 0.06±0.01 0.06±0.02 
β-Alanine 0.44±0.19 0.41±0.15 
Phenylalanine 0.10±0.02 0.12±0.01 
 28 
Ornithine 0.07±0.02 0.07±0.03 
Lysine 0.40±0.07 0.57±0.15 
Histidine 0.46±0.08 0.56±0.08 
Arginine 0.20±0.03 0.24±0.06 
 596 
Metabolites were assayed in liver extracts 72 hours following administration of 10 µg of pCpG-597 
siRNA-Scramble (Scramble) or chitosan-TPP-pCpG-sh2GDH (sh2) per gram BW. The values are 598 
expressed as mean ± SD (n=5). Statistical significance related to control fish (Scramble) is indicated 599 
as follows: *P < 0.05; **P < 0.01. 600 



